Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D.

Kennedy SA, Jarboui MA, Srihari S, Raso C, Bryan K, Dernayka L, Charitou T, Bernal-Llinares M, Herrera-Montavez C, Krstic A, Matallanas D, Kotlyar M, Jurisica I, Curak J, Wong V, Stagljar I, LeBihan T, Imrie L, Pillai P, Lynn MA, Fasterius E, Al-Khalili Szigyarto C, Breen J, Kiel C, Serrano L, Rauch N, Rukhlenko O, Kholodenko BN, Iglesias-Martinez LF, Ryan CJ, Pilkington R, Cammareri P, Sansom O, Shave S, Auer M, Horn N, Klose F, Ueffing M, Boldt K, Lynn DJ, Kolch W.

Nat Commun. 2020 Jan 24;11(1):499. doi: 10.1038/s41467-019-14224-9.

2.

The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Vukicevic S, Oppermann H, Verbanac D, Jankolija M, Popek I, Curak J, Brkljacic J, Pauk M, Erjavec I, Francetic I, Dumic-Cule I, Jelic M, Durdevic D, Vlahovic T, Novak R, Kufner V, Bordukalo Niksic T, Kozlovic M, Banic Tomisic Z, Bubic-Spoljar J, Bastalic I, Vikic-Topic S, Peric M, Pecina M, Grgurevic L.

Int Orthop. 2014 Mar;38(3):635-47. doi: 10.1007/s00264-013-2201-1. Epub 2013 Dec 19. Review.

3.

Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen.

Levatić J, Ćurak J, Kralj M, Šmuc T, Osmak M, Supek F.

J Med Chem. 2013 Jul 25;56(14):5691-708. doi: 10.1021/jm400328s. Epub 2013 Jul 8.

PMID:
23772653
4.

Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation.

Mak AB, Nixon AM, Kittanakom S, Stewart JM, Chen GI, Curak J, Gingras AC, Mazitschek R, Neel BG, Stagljar I, Moffat J.

Cell Rep. 2012 Oct 25;2(4):951-63. doi: 10.1016/j.celrep.2012.09.016. Epub 2012 Oct 19.

5.

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.

Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, Rossi L, De Pascale G, Curak J, Brown E, Tyers M, Wright GD.

Mol Syst Biol. 2011 Jun 21;7:499. doi: 10.1038/msb.2011.31.

6.

Detecting interactions with membrane proteins using a membrane two-hybrid assay in yeast.

Snider J, Kittanakom S, Damjanovic D, Curak J, Wong V, Stagljar I.

Nat Protoc. 2010 Jul;5(7):1281-93. doi: 10.1038/nprot.2010.83. Epub 2010 Jun 17.

PMID:
20595957
7.

Split-ubiquitin based membrane yeast two-hybrid (MYTH) system: a powerful tool for identifying protein-protein interactions.

Snider J, Kittanakom S, Curak J, Stagljar I.

J Vis Exp. 2010 Feb 1;(36). pii: 1698. doi: 10.3791/1698.

8.

Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6.

Deribe YL, Wild P, Chandrashaker A, Curak J, Schmidt MHH, Kalaidzidis Y, Milutinovic N, Kratchmarova I, Buerkle L, Fetchko MJ, Schmidt P, Kittanakom S, Brown KR, Jurisica I, Blagoev B, Zerial M, Stagljar I, Dikic I.

Sci Signal. 2009 Dec 22;2(102):ra84. doi: 10.1126/scisignal.2000576.

PMID:
20029029
9.

Yeast as a tool to study bacterial effectors.

Curak J, Rohde J, Stagljar I.

Curr Opin Microbiol. 2009 Feb;12(1):18-23. doi: 10.1016/j.mib.2008.11.004. Epub 2009 Jan 14. Review.

PMID:
19150254
10.

Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen.

Arnoldo A, Curak J, Kittanakom S, Chevelev I, Lee VT, Sahebol-Amri M, Koscik B, Ljuma L, Roy PJ, Bedalov A, Giaever G, Nislow C, Merrill AR, Lory S, Stagljar I.

PLoS Genet. 2008 Feb 29;4(2):e1000005. doi: 10.1371/journal.pgen.1000005. Erratum in: PLoS Genet. 2008 Apr;4(4). doi: 10.1371/annotation/76d35829-07a2-479f-bbc1-cce6755b6d8c. Merrill, Rod A [corrected to Merrill, A Rod].

Supplemental Content

Support Center